ClinVar Miner

Submissions for variant NM_000218.3(KCNQ1):c.1354C>T (p.Arg452Trp)

gnomAD frequency: 0.00016  dbSNP: rs140452381
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 11
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000148551 SCV000073997 likely benign Long QT syndrome 2023-12-11 criteria provided, single submitter clinical testing
CSER _CC_NCGL, University of Washington RCV000148551 SCV000190264 uncertain significance Long QT syndrome 2014-06-01 criteria provided, single submitter research Low GERP score may suggest that this variant may belong in a lower pathogenicity class
GeneDx RCV000224680 SCV000234491 uncertain significance not provided 2024-04-02 criteria provided, single submitter clinical testing Reported in association with LQTS and death during sleep (PMID: 28449774, 15840476); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 24055113, 22378279, 25637381, 25608792, 15840476, 29197658, 22581653, 28449774)
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics RCV000224680 SCV000281483 uncertain significance not provided 2016-04-08 criteria provided, single submitter clinical testing Converted during submission to Uncertain significance.
Ambry Genetics RCV000621439 SCV000738164 benign Cardiovascular phenotype 2023-05-22 criteria provided, single submitter clinical testing This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Fulgent Genetics, Fulgent Genetics RCV000764974 SCV000896151 uncertain significance Atrial fibrillation, familial, 3; Beckwith-Wiedemann syndrome; Long QT syndrome 1; Jervell and Lange-Nielsen syndrome 1; Short QT syndrome type 2 2018-10-31 criteria provided, single submitter clinical testing
Color Diagnostics, LLC DBA Color Health RCV001841631 SCV001344273 uncertain significance Cardiac arrhythmia 2023-05-01 criteria provided, single submitter clinical testing This missense variant replaces arginine with tryptophan at codon 452 of the KCNQ1 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual suspected to be affected with long QT syndrome (PMID: 15840476) and in an individual affected with sudden unexplained death (PMID: 28449774). It has also been reported in two healthy control individuals (PMID: 22378279). This variant has been identified in 25/281126 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The elevated variant allele frequency in the general population indicates that this variant may not be disease-causing. However, additional studies are necessary to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.
Center For Human Genetics And Laboratory Diagnostics, Dr. Klein, Dr. Rost And Colleagues RCV001248784 SCV001422294 uncertain significance Long QT syndrome 1 2020-02-18 criteria provided, single submitter clinical testing
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000224680 SCV004565164 uncertain significance not provided 2022-12-21 criteria provided, single submitter clinical testing The KCNQ1 c.1354C>T; p.Arg452Trp variant (rs140452381) is reported in the literature in an individual affected with long QT syndrome (Tester 2005) and an individual with sudden arrhythmic death syndrome (Lahrouchi 2017), but without clear association with disease. This variant is also reported in ClinVar (Variation ID: 52980), and is found in the African/African-American population with an allele frequency of 0.0097% (24/24776 alleles) in the Genome Aggregation Database. The arginine at codon 452 is moderately conserved, and computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.626). Due to limited information, the clinical significance of this variant is uncertain at this time. References: Lahrouchi N et al. Utility of Post-Mortem Genetic Testing in Cases of Sudden Arrhythmic Death Syndrome. J Am Coll Cardiol. 2017 May 2;69(17):2134-2145. PMID: 28449774. Tester DJ et al. Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. Heart Rhythm. 2005 May;2(5):507-17. PMID: 15840476.
All of Us Research Program, National Institutes of Health RCV000148551 SCV004836426 uncertain significance Long QT syndrome 2024-01-11 criteria provided, single submitter clinical testing This missense variant replaces arginine with tryptophan at codon 452 of the KCNQ1 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual suspected to be affected with long QT syndrome (PMID: 15840476) and in an individual affected with sudden unexplained death (PMID: 28449774). It has also been reported in two healthy control individuals (PMID: 22378279). This variant has been identified in 25/281126 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The elevated variant allele frequency in the general population indicates that this variant may not be disease-causing. However, additional studies are necessary to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.
Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust RCV000057582 SCV000089101 not provided Congenital long QT syndrome no assertion provided literature only This variant has been reported as associated with Long QT syndrome in the following publications (PMID:15840476;PMID:22378279). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.